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Diffuse skeletal coccidioidomycosis in an AIDS patient§
Figure 2. Hematoxylin and eosin stained histopathology from iliac lesion biopsy,
10 (A), 40 (B), and 100 (C) magniﬁcation. Gomori’s methenamine silver (GMS)
stain of tissue (D) highlighting thick fungal cell wall and spherules containing
endospores consistent with Coccidioides immitis.
Figure 1. MRI revealing diffuse T1-weighted enhancing lesions involving the spine
(A) and pelvis (B).
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(13%), viral load of 31,800 copies/ml, and history of coccidioidomy-
cosis localized to the lymph nodes, presented with progressive back
pain. He was non-adherent with ﬂuconazole and antiretrovirals
(raltegravir + tenofovir/emtricitabine). A physical exam was signiﬁ-
cant only for fever of 39.6 8C. Spinal magnetic resonance imaging
(MRI) revealed diffuse T1-weighted enhancing lesions involving the
spine and pelvis (Figure 1). CT-guided left iliac biopsies yielded
histopathology consistent with Coccidioides immitis infection
(Figure 2). Bone culture grew C. immitis and serum serology was
positive. He was treated with liposomal amphotericin B for 2 weeks
with clinical improvement and transitioned to oral ﬂuconazole.
Coccidioidomycosis is a fungal infection endemic to northern
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Skeletal involvement occurs in approximately 20–50% of dissemi-
nated infections.1 Dissemination is more common in the immu-
nosuppressed, those of Filipino or African American race, and in
pregnancy. Those with HIV are at risk for dissemination when CD4
counts are less than 250/ml, and skeletal disease is now rare in the
antiretroviral era.2,3 The gold standard for diagnosis is histopa-
thology of bone and culture, with serology being adjunctive.1
Therapy includes oral azoles, typically ﬂuconazole or itraconazole.4
A randomized, double-blind, placebo-controlled trial of ﬂucona-
zole versus itraconazole showed a superior response to itracona-
zole in patients with skeletal infections.5 Amphotericin B is
recommended for alternative therapy if lesions are in critical areas,
such as the spine, or are rapidly worsening.4
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